Bellevue Healthcare Trust plc
BBH.L · LSE
5/31/2025 | 11/30/2024 | 5/31/2024 | 11/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -0.02% | 0.00% | -0.61% | -0.70% |
| EV / EBITDA | -3.27 | 11.38 | 14.45 | -8.97 |
| Quality | ||||
| ROIC | -33.24% | 7.48% | 6.14% | -8.34% |
| Gross Margin | 0.00% | 90.99% | 93.41% | 105.58% |
| Cash Conversion Ratio | 0.00 | -0.07 | -0.09 | 0.07 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -14.38% | – |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.33 | -8.29 | -0.41 | 1.13 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.03 |
| Cash Conversion Cycle | -186.91 | -6,934.26 | -38.22 | 2,719.44 |